Mycobacterium fortuitum peritonitis associated with CAPD: diagnosis by a molecular biology technique.
Kawamoto
S
S
Otani
K
K
Kawaguchi
Y
Y
Hosoya
T
T
D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018441:Biofilms; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008967:Molecular Biology; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis*; D019907:Mycobacterium fortuitum / Q000145:classification / Q000235:genetics; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000295:instrumentation*; D010538:Peritonitis / Q000382:microbiology*; D012336:RNA, Ribosomal, 16S / Q000032:analysis; D013407:Sulbactam / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D012336:RNA, Ribosomal, 16S; D000583:Amikacin; D013407:Sulbactam